Inhibition of TAK1 and/or JAK can rescue impaired chondrogenic differentiation of human mesenchymal stem cells in osteoarthritis-like conditions
Tissue Engineering Part A doi:10/1089/ten.TEA.2013.0553
View and download slide summaries of the latest original articles focusing on therapies in immune-mediated inflammatory diseases including rheumatology, dermatology, and gastroenterology. All materials produced by the team are subsequently reviewed and approved by individual Steering Committee members.
Tissue Engineering Part A doi:10/1089/ten.TEA.2013.0553
Ann Rheum Dis doi:10.1136/annrheumdis-2013-204588
Ann Rheum Dis doi:10.1136/annrheumdis-2013-204575
DMD doi:10.1124/dmd.113.054940
Rheumatology doi:10.1093/rheumatology/ket466
Chemistry and Biology Nov 13 20, 1364-1374
Arthritis Research and Therapy 2013 15:R146
Arthritis and Rheumatism doi: 10.1002/art.38305
Bone 2014;60:8-15
Curr. Opin. Rheumatol. 2014; 26:85–92. doi:10.1097/BOR.0000000000000012